Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""breast carcinoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 11478
Tytuł:
Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Autorzy:
Jani C; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Lotz M; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Keates S; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Gupta Y; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Walker A; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Al Omari O; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Parvez A; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.
Patel D; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Gnata M; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Perry J; Department of Pathology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Khorashadi L; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Department of Radiology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Weissmann L; Department of Internal Medicine, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Division of Hematology-Oncology, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Pories SE; Harvard Medical School, 25 Shattuck St, Boston 02115, MA, USA.; Hoffman Breast Center, Department of Surgery, Mount Auburn Hospital, 300 Mount Auburn St., Cambridge, MA, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2023 Apr 18; Vol. 2023, pp. 8185446. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Breast Carcinoma In Situ*/diagnostic imaging
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Carcinoma in Situ*/diagnosis
Carcinoma in Situ*/pathology
Carcinoma in Situ*/surgery
Carcinoma, Intraductal, Noninfiltrating*/diagnostic imaging
Carcinoma, Intraductal, Noninfiltrating*/surgery
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/surgery
Precancerous Conditions*/pathology
Female ; Humans ; Biopsy ; Biopsy, Large-Core Needle ; Hyperplasia ; Observational Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proliferative epithelial changes in tumour adjacent tissue in Sri Lankan women with breast carcinoma: do morphological changes support molecular models of breast carcinogenesis?
Autorzy:
Jinadasa IM; Department of Histopathology, National Hospital of Sri Lanka, Colombo, Sri Lanka. .
Wijesinghe HD; Department of Pathology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Jayawickrama MMA; Department of Histopathology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Lokuhetty MDS; Department of Pathology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Dec 29; Vol. 17 (1), pp. 97. Date of Electronic Publication: 2022 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Carcinoma, Intraductal, Noninfiltrating*/pathology
Breast Carcinoma In Situ*/pathology
Carcinoma, Ductal, Breast*/pathology
Humans ; Female ; Sri Lanka ; Cross-Sectional Studies ; Mastectomy ; Carcinogenesis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Autorzy:
Lee J; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Ku GY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Lee H; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park HS; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Ku JS; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Kim JY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park S; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Park BW; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1074-1080. Date of Electronic Publication: 2021 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*/diagnosis
Breast Carcinoma In Situ*/pathology
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/diagnosis
Breast Neoplasms*/surgery
Calcinosis*/diagnosis
Calcinosis*/surgery
Carcinoma in Situ*/pathology
Carcinoma, Intraductal, Noninfiltrating*/diagnosis
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Intraductal, Noninfiltrating*/surgery
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/pathology
Carcinoma, Lobular*/surgery
Biopsy ; Female ; Humans ; Receptors, Progesterone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Autorzy:
Fox SB; Department of Pathology, Peter MacCallum Cancer Centre, Level 4 Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia.
Webster F; International Collaboration on Cancer Reporting, Surry Hills, NSW, Australia.
Chen CJ; Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chua B; Prince of Wales Clinical School, UNSW Sydney, The University of New South Wales, Randwick, NSW, Australia.
Collins L; Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, and Harvard Medical School, Boston, MA, USA.
Foschini MP; Department Anatomic Pathology, University of Bologna, Department of Biomedical and Neuromotor Sciences Unit of Anatomic Pathology at Bellaria Hospital, Bologna, Italy.
Bruce Mann G; The Breast Service, The Royal Melbourne Hospital, Parkville, VIC, Australia.
Millar E; Department of Anatomical Pathology, NSW Heath Pathology St George Hospital, Kogarah NSW 2217 & St George & Sutherland Clinical School, Sydney, Australia.
Pinder SE; School of Cancer & Pharmaceutical Sciences, King's College London, 9th Floor, Innovation Hub, Comprehensive Cancer Centre at Guy's Hospital, London, UK.
Rakha E; Department of Histopathology, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Shaaban A; Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham and Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Tan BY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Tse G; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Watson P; Department of Pathology, Biobanking and Biospecimen Research Services, Deeley Research Centre, BC Cancer Agency, Canada Victoria, British Columbia, Canada.
Tan PH; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Oct; Vol. 81 (4), pp. 467-476. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*
Carcinoma in Situ*
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Lobular*/pathology
Carcinoma, Papillary*
Female ; Humans ; Hyperplasia ; Pathologists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lobular Carcinoma In Situ Incidentally Detected by Dual-Energy Computed Tomography
Autorzy:
Erdemir AG; Department of Radiology, Faculty of Medicine Hacettepe University, Ankara, Turkey
Durhan G; Department of Radiology, Faculty of Medicine Hacettepe University, Ankara, Turkey
Akpınar E; Department of Radiology, Faculty of Medicine Hacettepe University, Ankara, Turkey
Pokaż więcej
Źródło:
Balkan medical journal [Balkan Med J] 2022 May 24; Vol. 39 (3), pp. 218-219. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*
Breast Neoplasms*/diagnostic imaging
Female ; Humans ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Classical Lobular Carcinoma In Situ Arising From an Intraductal Papilloma of the Breast: A Case Report.
Autorzy:
Kim NI; Department of Pathology, Chonnam National University Medical School, Gwangju, South Korea.
Park MH; Department of Pathology, Chonnam National University Medical School, Gwangju, South Korea.
Lee JS; Department of Pathology, Chonnam National University Medical School, Gwangju, South Korea.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2021 Aug; Vol. 29 (5), pp. 534-537. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Breast Carcinoma In Situ/*diagnosis
Breast Neoplasms/*diagnosis
Carcinoma, Lobular/*diagnosis
Neoplasms, Second Primary/*diagnosis
Papilloma, Intraductal/*diagnosis
Aged ; Antigens, CD/analysis ; Biomarkers, Tumor/analysis ; Breast/pathology ; Breast/surgery ; Breast Carcinoma In Situ/pathology ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Cadherins/analysis ; Carcinoma, Lobular/pathology ; Carcinoma, Lobular/surgery ; Female ; Humans ; Mastectomy ; Neoplasms, Second Primary/pathology ; Neoplasms, Second Primary/surgery ; Papilloma, Intraductal/pathology ; Papilloma, Intraductal/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward.
Autorzy:
Czaja R; From the Department of Pathology (Czaja, Jorns), Medical College of Wisconsin, Milwaukee.
Wu R; Department of Biostatistics (Wu), Medical College of Wisconsin, Milwaukee.
Jorns JM; From the Department of Pathology (Czaja, Jorns), Medical College of Wisconsin, Milwaukee.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Aug 01; Vol. 145 (8), pp. 1018-1024.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Frozen Sections*
Sentinel Lymph Node Biopsy*
Breast Carcinoma In Situ/*secondary
Breast Neoplasms/*pathology
Carcinoma, Ductal, Breast/*secondary
Carcinoma, Lobular/*secondary
Lymph Nodes/*pathology
Adult ; Aged ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Intraductal, Noninfiltrating/secondary ; Carcinoma, Intraductal, Noninfiltrating/surgery ; Carcinoma, Lobular/surgery ; False Negative Reactions ; Female ; Humans ; Lymph Nodes/surgery ; Lymphatic Metastasis ; Medical Audit ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Staining and Labeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Lobular intraepithelial neoplasia: Outcomes and optimal management.
Autorzy:
Boland PA; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Dunne EC; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Kovanaite A; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Stokes M; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Kell MR; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Barry JM; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Kennedy M; Department of Histopathology, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Flanagan F; Department of Breast Radiology, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Walsh SM; Department of Breast Surgery, Breast Health Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Dec; Vol. 26 (12), pp. 2383-2390. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*/diagnostic imaging
Breast Carcinoma In Situ*/epidemiology
Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/surgery
Carcinoma in Situ*/diagnosis
Carcinoma in Situ*/epidemiology
Carcinoma in Situ*/surgery
Carcinoma, Lobular*/diagnosis
Carcinoma, Lobular*/epidemiology
Carcinoma, Lobular*/surgery
Biopsy, Large-Core Needle ; Female ; Humans ; Hyperplasia ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal study of breast cancer risk markers.
Autorzy:
Zarwan C; Lahey Hospital and Medical Center, Burlington, MA, USA.; Tufts School of Medicine, Boston, MA, USA.
Diamond O; Mount Auburn Hospital, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Lam P; Mount Auburn Hospital, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Ghebremichael MS; Harvard School of Public Health and Ragon Institute, Cambridge, MA, USA.
Lotz M; Mount Auburn Hospital, Cambridge, MA, USA.
Shen AH; HMS IV, Harvard Medical School, Boston, MA, USA.
Sharifi S; Lahey Hospital and Medical Center, Burlington, MA, USA.; Tufts School of Medicine, Boston, MA, USA.
Rozhansky F; Spaulding Rehabilitation Hospital, Cambridge, MA, USA.
Gore TA; Merrimack Valley Internal Medicine Associates, North Chelmsford, MA, USA.
Pories SE; Mount Auburn Hospital, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2021 Jan; Vol. 27 (1), pp. 48-51. Date of Electronic Publication: 2020 Oct 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Carcinoma In Situ*/pathology
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/epidemiology
Breast Neoplasms*/pathology
Carcinoma in Situ*/pathology
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/epidemiology
Carcinoma, Lobular*/pathology
Breast/pathology ; Female ; Humans ; Hyperplasia/pathology ; Longitudinal Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy.
Autorzy:
Singh K; Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, Providence, RI, USA.
Sung CJ; Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, Providence, RI, USA.
Quddus MR; Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, Providence, RI, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Dec; Vol. 26 (12), pp. 2350-2356. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*
Carcinoma in Situ*/surgery
Carcinoma, Lobular*
Biopsy, Large-Core Needle ; Female ; Humans ; Neoplasm Recurrence, Local
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
Autorzy:
Calle C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Faculdade de Ciencias da Saude da Universidade da Beira Interior, Covilha, Portugal.
Kuba MG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Brogi E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Jun; Vol. 26 (6), pp. 1148-1155. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
Breast Carcinoma In Situ*/diagnostic imaging
Breast Carcinoma In Situ*/genetics
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Breast Neoplasms*/therapy
Carcinoma in Situ*/pathology
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/genetics
Carcinoma, Lobular*/therapy
Biopsy, Large-Core Needle ; Breast/diagnostic imaging ; Breast/pathology ; Breast/surgery ; Female ; Humans ; Hyperplasia/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extensive Florid Lobular carcinoma in situ presenting as a large breast mass requiring a mastectomy.
Autorzy:
Tison NRR; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore City, Singapore.; SingHealth-Duke NUS Breast Centre, Singapore City, Singapore.
Leong L; Department of Diagnostic Radiology, Singapore General Hospital, Singapore City, Singapore.
Tan PH; Department of Anatomical Pathology, Singapore General Hospital, Singapore City, Singapore.
Tan VKM; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore City, Singapore.; SingHealth-Duke NUS Breast Centre, Singapore City, Singapore.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 May; Vol. 26 (5), pp. 1025-1027. Date of Electronic Publication: 2019 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*/diagnostic imaging
Breast Carcinoma In Situ*/surgery
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/surgery
Carcinoma in Situ*/surgery
Carcinoma, Lobular*/diagnostic imaging
Carcinoma, Lobular*/surgery
Breast ; Female ; Humans ; Mastectomy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pleomorphic lobular carcinoma in situ composed of signet ring cells mimicking cribriform ductal carcinoma in situ.
Autorzy:
Kavesh M; Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Martinez M; Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.
Asirvatham JR; Department of Pathology, Baylor Scott and White Health, Gainesville, Florida, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Oct; Vol. 26 (10), pp. 2050-2051. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ*
Breast Neoplasms*
Carcinoma in Situ*
Carcinoma, Ductal, Breast*
Carcinoma, Intraductal, Noninfiltrating*
Carcinoma, Lobular*/diagnostic imaging
Female ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Management of women at increased risk for breast cancer secondary to high-risk proliferative lesions and family history of the disease.
Autorzy:
Cen C; Department of Surgery, New York University Langone Health, New York, NY, USA.
Chun J; Department of Surgery, New York University Langone Health, New York, NY, USA.
Schnabel F; Department of Surgery, New York University Langone Health, New York, NY, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Aug; Vol. 26 (8), pp. 1543-1548. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Carcinoma In Situ*/pathology
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Carcinoma, Lobular*/pathology
Breast/diagnostic imaging ; Breast/pathology ; Breast/surgery ; Female ; Humans ; Hyperplasia/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[Adherence to adjuvant hormonal therapy in patients with breast cancer].
Autorzy:
Camejo-Martínez N; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay .
Castillo-Leska C; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Artagaveytia-Cóppola NA; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Hernández-Ibero AL; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Amarillo-Hernández DL; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Apud-Yumati PS; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Melo-Ramundo F; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Delgado-Pebe LB; Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Servicio de Oncología. Montevideo, Uruguay.
Pokaż więcej
Transliterated Title:
Adhesión a la hormonoterapia adyuvante en pacientes con cáncer de mama.
Źródło:
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2019 Dec 30; Vol. 57 (6), pp. 357-363. Date of Electronic Publication: 2019 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Carcinoma In Situ/*drug therapy
Breast Neoplasms/*drug therapy
Carcinoma, Ductal, Breast/*drug therapy
Medication Adherence/*statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; Aromatase Inhibitors/therapeutic use ; Breast Carcinoma In Situ/pathology ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/surgery ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Patient Dropouts ; Retrospective Studies ; Tamoxifen/therapeutic use ; Time Factors ; Uruguay
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters.
Autorzy:
Hashmi AA; Liaquat National Hospital and Medical College, Karachi, Pakistan.
Hashmi KA; Nishtar Medical College Hospital, Multan, Pakistan.
Irfan M; Liaquat National Hospital and Medical College, Karachi, Pakistan.
Khan SM; Liaquat National Hospital and Medical College, Karachi, Pakistan.
Edhi MM; Brown University, Providence, RI, USA.
Ali JP; Liaquat National Hospital and Medical College, Karachi, Pakistan.
Hashmi SK; CMH Institute of Medical Sciences, Multan, Pakistan.
Asif H; CMH Institute of Medical Sciences, Multan, Pakistan.
Faridi N; Liaquat National Hospital and Medical College, Karachi, Pakistan.
Khan A; Kandahar University, Kandahar, 3802, Afghanistan. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2019 Sep 23; Vol. 12 (1), pp. 605. Date of Electronic Publication: 2019 Sep 23.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*diagnosis
Adenocarcinoma, Mucinous/*diagnosis
Biomarkers, Tumor/*genetics
Breast Carcinoma In Situ/*diagnosis
Breast Neoplasms/*diagnosis
Carcinoma, Ductal, Breast/*diagnosis
Carcinoma, Medullary/*diagnosis
Ki-67 Antigen/*genetics
Triple Negative Breast Neoplasms/*diagnosis
Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Adenocarcinoma, Mucinous/genetics ; Adenocarcinoma, Mucinous/pathology ; Adult ; Aged ; Biomarkers, Tumor/metabolism ; Breast Carcinoma In Situ/genetics ; Breast Carcinoma In Situ/pathology ; Breast Neoplasms/classification ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Carcinoma, Ductal, Breast/genetics ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Medullary/genetics ; Carcinoma, Medullary/pathology ; Diagnosis, Differential ; Female ; Gene Expression ; Humans ; Ki-67 Antigen/metabolism ; Middle Aged ; Neoplasm Grading ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Terminology as Topic ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
Autorzy:
Dintzis SM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Hansen S; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Harrington KM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Tan LC; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Miller DM; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Ishak L; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Parrish-Novak J; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Kittle D; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Perry J; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Gombotz C; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Fortney T; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Porenta S; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Hales L; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Calhoun KE; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Anderson BO; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Javid SH; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Byrd DR; From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz), Research (Ms Hansen and Dr Parrish-Novak), and Device Development (Dr Kittle and Mr Perry), Blaze Bioscience, Inc., Seattle, Washington; and the Department of Surgery, University of Washington, Seattle (Dr Anderson).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2019 Sep; Vol. 143 (9), pp. 1076-1083. Date of Electronic Publication: 2018 Dec 14.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Fluorescent Dyes*
Scorpion Venoms*
Breast Carcinoma In Situ/*diagnostic imaging
Breast Neoplasms/*diagnostic imaging
Carcinoma, Ductal, Breast/*diagnostic imaging
Carcinoma, Lobular/*diagnostic imaging
Indocyanine Green/*analogs & derivatives
Breast Carcinoma In Situ/pathology ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/pathology ; Carcinoma, Ductal, Breast/surgery ; Carcinoma, Lobular/pathology ; Carcinoma, Lobular/surgery ; Female ; Humans ; Intraoperative Care/methods ; Margins of Excision ; Mastectomy ; Mastectomy, Segmental ; Neoplasm Invasiveness/diagnostic imaging ; Neoplasm Invasiveness/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Triaging Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Percutaneous Core Biopsy to Surgery or Observation: Assiduous Radiologic-Pathologic Correlation Works, Quantitating Extent of Disease Does Not.
Autorzy:
Holbrook AI; From the Departments of Radiology and Imaging Sciences (Drs Holbrook and Cohen), Pathology and Laboratory Medicine (Dr Hanley), and Biostatistics and Bioinformatics (Ms Jeffers), Rollins School of Public Health, Emory University, Atlanta, Georgia; and the Department of Biostatistics, University of Michigan, Ann Arbor (Dr Kang).
Hanley K
Jeffers C
Kang J
Cohen MA
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2019 May; Vol. 143 (5), pp. 621-627. Date of Electronic Publication: 2018 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Carcinoma In Situ/*diagnostic imaging
Breast Carcinoma In Situ/*pathology
Breast Neoplasms/*diagnostic imaging
Breast Neoplasms/*pathology
Precancerous Conditions/*diagnostic imaging
Precancerous Conditions/*pathology
Adult ; Aged ; Aged, 80 and over ; Biopsy, Large-Core Needle ; Breast Carcinoma In Situ/surgery ; Breast Neoplasms/surgery ; Female ; Humans ; Hyperplasia/diagnosis ; Hyperplasia/pathology ; Middle Aged ; Retrospective Studies ; Triage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.
Autorzy:
Upadhyaya VS; Department of Radiology, Sengkang General Hospital, Singapore.
Lim GH; Breast Department, KK Women's and Children's Hospital, Singapore.
Chan EYK; Department of Radiology, Sengkang General Hospital, Singapore.
Fook-Chong SMC; Division of Medicine, Singapore General Hospital, Singapore.
Leong LCH; Department of Diagnostic Radiology, Singapore General Hospital, Singapore.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Feb; Vol. 26 (2), pp. 162-167. Date of Electronic Publication: 2019 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Axilla/*diagnostic imaging
Breast Carcinoma In Situ/*pathology
Breast Neoplasms/*pathology
Lymphatic Metastasis/*diagnostic imaging
Ultrasonography/*standards
Aged ; Breast Carcinoma In Situ/diagnostic imaging ; Breast Neoplasms/diagnostic imaging ; Case-Control Studies ; Female ; Humans ; Lymphatic Metastasis/pathology ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Preoperative Care/methods ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 11478

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies